Author:
Lum Catherine K.,Wilson Darrell M.
Reference89 articles.
1. Raben MS. Treatment of pituitary dwarf with human growth hormone. J Clin Endocrinol Metabol 1958; 18: 901–903.
2. Hintz RL. The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment. J Clin Endocrinol Metabol 1995; 80: 2298–2301.
3. Fradkin JE, Schonberger LB, Mills JL, Gunn WJ, Piper JM, Wysowski DK, Thomson R, Durako S, Brown P. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. J Am Med Assoc 1991; 265: 880–884.
4. National Center for Health Statistics:NCHS Growth Curves for Children 0–18 years, United States, Vital and Health Statistics, Series 11, no. 165, Washington, D.C. Health Resources Administration, U.S. Government Printing Office, 1977.
5. Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107: 317–329.